Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer

Clinical trial NCT00182052 · COMPLETED

Trial details

NCT number: NCT00182052
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Prostate Cancer

Start date: 2000-09-01
Primary completion: 2003-08-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.